New combo therapy aims to boost red blood cells in MDS patients
NCT ID NCT05181735
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a combination of two drugs—luspatercept and erythropoietin (EPO)—for people with a low-risk form of myelodysplastic syndrome (MDS) that does not involve ring sideroblasts. Participants must have already tried EPO alone without success or be unable to take it. The goal is to find the best dose and see if the combination works better than luspatercept alone at improving blood counts. About 150 adults will take part in this early-phase trial.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MDS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AOU Careggi
NOT_YET_RECRUITINGFlorence, 50134, Italy
-
CH Henri Duffaut d'Avignon
RECRUITINGAvignon, 84000, France
-
CH Le Mans
RECRUITINGLe Mans, 72037, France
-
CHR d'Orléans
RECRUITINGOrléans, 45067, France
-
CHRU Nancy - Hôpitaux de Brabois
RECRUITINGVandœuvre-lès-Nancy, 54511, France
-
CHRU de Lille - Hôpital Claude Huriez
NOT_YET_RECRUITINGLille, 59037, France
-
CHRU de Limoges - Hôpital Dupuytren
NOT_YET_RECRUITINGLimoges, 87042, France
-
CHU Amiens-Picardie
RECRUITINGAmiens, 80054, France
-
CHU Angers
RECRUITINGAngers, 49933, France
-
CHU Nantes - Hôtel Dieu
RECRUITINGNantes, 44093, France
-
CHU Saint Eloi
RECRUITINGMontpellier, 34295, France
-
CHU Toulouse - IUCT Oncopole
RECRUITINGToulouse, 31059, France
-
CHU de Bordeaux - Hôpital Haut-Lévêque
RECRUITINGPessac, 33604, France
-
CHU de Grenoble
RECRUITINGGrenoble, 38043, France
-
CHU de Nice - Hôpital Archet 1
RECRUITINGNice, 06202, France
-
CHU de Nîmes
RECRUITINGNîmes, 30029, France
-
CHU de Poitiers
RECRUITINGPoitiers, 86021, France
-
CHU de Rennes - Hôpital Pontchaillou
RECRUITINGRennes, 35033, France
-
CHU de Tours - Hôpital Bretonneau
RECRUITINGTours, 37000, France
-
Centre Henri Becquerel
RECRUITINGRouen, 76038, France
-
Centre Hospitalier Lyon Sud
NOT_YET_RECRUITINGPierre-Bénite, 69495, France
-
Centre Hospitalier Victor Dupouy
RECRUITINGArgenteuil, 95107, France
-
Centre Hospitalier de Cornouaille
NOT_YET_RECRUITINGQuimper, 29107, France
-
Centre Hospitalier de Mont de Marsan
NOT_YET_RECRUITINGMont-de-Marsan, 40000, France
-
Centre Hospitalier de Périgueux
RECRUITINGPérigueux, 24019, France
-
Centre Hospitalier de Valence
RECRUITINGValence, 26000, France
-
Centre Hospitalier de Versailles
NOT_YET_RECRUITINGLe Chesnay, 78150, France
-
Centre Hospitalier de la Côte Basque
NOT_YET_RECRUITINGBayonne, 64109, France
-
Clinique de l'Europe
NOT_YET_RECRUITINGAmiens, 80090, France
-
Hôpital Avicenne
RECRUITINGBobigny, 93009, France
-
Hôpital Bicêtre
RECRUITINGLe Kremlin-Bicêtre, 94270, France
-
Hôpital Cochin
NOT_YET_RECRUITINGParis, 75014, France
-
Hôpital NOVO
NOT_YET_RECRUITINGPontoise, 95300, France
-
Hôpital Necker
RECRUITINGParis, 75015, France
-
Hôpital Privé Sévigné
RECRUITINGCesson-Sévigné, 35510, France
-
Hôpital Saint Louis
RECRUITINGParis, 75010, France
-
Hôpital privé du Confluent
RECRUITINGNantes, 44277, France
-
IRCCS
RECRUITINGCandiolo, 10060, Italy
-
Institut de Cancérologie et d'Hématologie Universitaire de Saint-Etienne
RECRUITINGSaint-Priest-en-Jarez, 42271, France
-
Strasbourg Oncologie Libérale Clinique Sainte Anne
RECRUITINGStrasbourg, 67000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Frailty check may steer safer cancer care for seniors
- Talking about the end: could guided conversations reduce futile cancer treatments?
- Can engineered immune cells outsmart Hard-to-Treat blood cancers?
- Can a new drug offer hope for blood cancers when chemo fails?